New aspects of the influence of immunity and microbiome on heart transplant rejection
Currently, heart transplantation is the key treatment for patients with end-stage heart failure. At the same time, the immunopathogenesis of chronic allograft rejection, which is a key factor in the long-term outcome, is still poorly understood, which, in turn, explains the absence of effective non-...
Saved in:
Main Authors: | A. S. Golovkin, I. V. Kudryavtsev, P. A. Fedotov, O. V. Kalinina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2022-09-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4806 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ST2 IN REJECTION OF THE TRANSPLANTED HEART
by: O. P. Shevchenko, et al.
Published: (2016-01-01) -
Galectin-3 in heart transplant rejection and fibrosis
by: O. P. Shevchenko, et al.
Published: (2019-10-01) -
MORPHOLOGICAL INDICATORS OF MYOCARDIAL DAMAGES IN REJECTION OF TRANSPLANTED HEART
by: A. A. VEREVKIN, et al.
Published: (2017-12-01) -
Antibody-mediated rejection in heart transplantation
by: V. S. Kvan, et al.
Published: (2022-01-01) -
FEATURES OF CLINICAL DISPLAYS OF THE TRANSPLANTED HEART ACUTE REJECTION
by: S. J. Shemakin, et al.
Published: (2010-06-01)